New Delhi, India

D N K Sarma

This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Immunology. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: D N K Sarma. Retrieved from https://idiyas.com/inventor/d-n-k-sarma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: D N K Sarma: Innovator in Immunology

Introduction

D N K Sarma is a notable inventor based in New Delhi, India. He has made significant contributions to the field of immunology, particularly in the area of graft versus host disease and septic shock syndrome. His innovative work has led to the development of a unique method that addresses critical health challenges.

Latest Patents

D N K Sarma holds a patent for a method aimed at suppressing allogenic immune response, which is crucial for the prevention and treatment of graft versus host disease. The patent details the use of Berberine or its pharmaceutically acceptable salts, either alone or in combination with cyclosporin, to effectively treat or prevent these conditions. This innovative approach also extends to the treatment of septic shock syndrome, showcasing the versatility of his research.

Career Highlights

Sarma is affiliated with the National Institute of Immunology, where he conducts his research and development activities. His work at this esteemed institution has positioned him as a key figure in advancing immunological studies and therapies.

Collaborations

Some of his notable coworkers include Shakti N Upadhyay and Nalini Wali, who contribute to the collaborative efforts in their research endeavors.

Conclusion

D N K Sarma's contributions to immunology through his innovative patent reflect his commitment to addressing significant medical challenges. His work continues to inspire advancements in the field and offers hope for improved treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…